Difference between revisions of "Bendamustine"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(updated content)
Line 4: Line 4:
 
Class/mechanism: Nitrogen mustard, alkylator; bifunctional mechlorethamine derivative containing a purine-like benzimidazole ring which forms electrophilic alkyl groups, resulting in interstrand DNA crosslinks, leading to cell death via several pathways in both quiescent and dividing cells.<ref name="insert">[http://www.treanda.com/pdf/TREANDA_final_PI.pdf Bendamustine (Treanda) package insert]</ref><ref>[[Media:Bendamustine.pdf | Bendamustine (Treanda) package insert (locally hosted backup)]]</ref><ref>[http://treanda.com/ Treanda manufacturer's website]</ref>
 
Class/mechanism: Nitrogen mustard, alkylator; bifunctional mechlorethamine derivative containing a purine-like benzimidazole ring which forms electrophilic alkyl groups, resulting in interstrand DNA crosslinks, leading to cell death via several pathways in both quiescent and dividing cells.<ref name="insert">[http://www.treanda.com/pdf/TREANDA_final_PI.pdf Bendamustine (Treanda) package insert]</ref><ref>[[Media:Bendamustine.pdf | Bendamustine (Treanda) package insert (locally hosted backup)]]</ref><ref>[http://treanda.com/ Treanda manufacturer's website]</ref>
 
<br>Route: IV
 
<br>Route: IV
<br>Extravasation: no information
+
<br>Extravasation: [[vesicant]]
  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://reference.medscape.com/drug/treanda-bendamustine-342133 Medscape], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://reference.medscape.com/drug/treanda-bendamustine-342133 Medscape], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
Line 27: Line 27:
 
[[Category:Drug index]]
 
[[Category:Drug index]]
 
[[Category:Chemotherapy]]
 
[[Category:Chemotherapy]]
 +
[[Category:Vesicant chemotherapy]]
 
[[Category:Nitrogen mustards]]
 
[[Category:Nitrogen mustards]]
 
[[Category:Alkylating agents]]
 
[[Category:Alkylating agents]]
 
[[Category:Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) medications]]
 
[[Category:Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) medications]]
 +
[[Category:Follicular lymphoma medications]]
 +
[[Category:Hodgkin lymphoma medications]]
 +
[[Category:Mantle cell lymphoma medications]]
 +
[[Category:Multiple myeloma medications]]
 
[[Category:Non-Hodgkin lymphoma medications]]
 
[[Category:Non-Hodgkin lymphoma medications]]
 +
[[Category:T-cell lymphoma medications]]

Revision as of 02:54, 16 August 2013

Also known as Bendamustine Hydrochloride, Ribomustin, SDX-105, or Treakisym.

General information

Class/mechanism: Nitrogen mustard, alkylator; bifunctional mechlorethamine derivative containing a purine-like benzimidazole ring which forms electrophilic alkyl groups, resulting in interstrand DNA crosslinks, leading to cell death via several pathways in both quiescent and dividing cells.[1][2][3]
Route: IV
Extravasation: vesicant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, Medscape, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

References